SCHEMBL6879249

SCHEMBL6879249

CCCCC(=O)OC(=O)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CES1 P23141 2/20 0.42
CES2 O00748 1/20 0.42
DGKA P23743 1/20 0.42
LMNA P02545 2/20 0.39
TP53 P04637 1/20 0.39
PAM P19021 2/20 0.38
CA1 P00915 1/20 0.38
NAAA Q02083 1/20 0.38
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
PRSS1 P07477 1/20 0.37
CTSG P08311 1/20 0.37
CTRB1 P17538 1/20 0.37
CMA1 P23946 1/20 0.37
MIF P14174 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9485726 0.94 ALDH1A1 (0.50) ALDH1A1CES1CES2DGKALMNA
SCHEMBL9485730 0.94 ALDH1A1 (0.50) ALDH1A1CES1CES2DGKALMNA
SCHEMBL6899017 0.94 DGKA (0.50) ALDH1A1CES1CES2DGKALMNA
SCHEMBL31155339 0.92 DGKA (0.53) ALDH1A1CES1CES2DGKALMNA
SCHEMBL29126817 0.92 DGKA (0.53) ALDH1A1CES1CES2DGKALMNA
SCHEMBL8882128 0.92 DGKA (0.53) ALDH1A1CES1CES2DGKALMNA
SCHEMBL27593607 0.92 DGKA (0.53) ALDH1A1CES1CES2DGKALMNA
SCHEMBL666141 0.92 DGKA (0.53) ALDH1A1CES1CES2DGKALMNA
SCHEMBL8883996 0.92 DGKA (0.53) ALDH1A1CES1CES2DGKALMNA
SCHEMBL18126434 0.89 TSHR (0.40) ALDH1A1DGKALMNAPAMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1462467-A1 A process for the production of silyl group containing polymer resin Sigma Kalon Services B.V. (NL) 2004-09-29 EP claimed
CN-111372942-A β -catenin function modulating agents and methods thereof 弗格制药有限公司 2020-07-03 CN disclosed
CN-104169286-B Be used for the treatment of the macrocyclic derivatives of proliferative diseases 辉瑞大药厂 2016-06-08 CN disclosed
CN-104870435-A Aryl and heteroaryl fused lactams PFIZER 2015-08-26 CN disclosed
CN-104174071-A COMPOSITIONS AND SYSTEMS FOR FORMING CROSSLINKED BIOMATERIALS AND ASSOCIATED METHODS OF PREPARATION AND USE ANGIODEVICE INTERNAT GMBH 2014-12-03 CN disclosed
CN-104169286-A Macrocyclic derivatives for the treatment of proliferative diseases PFIZER 2014-11-26 CN disclosed
CN-101080246-A Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use ANGIOTECH INT AG (CH) 2007-11-28 CN disclosed
CN-1747936-A Substituted azole derivatives as therapeutic agents TRANSTECH PHARMA INC (US) 2006-03-15 CN disclosed
EP-1462467-A1 A process for the production of silyl group containing polymer resin Sigma Kalon Services B.V. (NL) 2004-09-29 EP disclosed
EP-0342276-B1 A PROCESS FOR PREPARING A METAL CONTAINING RESIN COMPOSITION AND THE USE OF THE COMPOSITION THUS PREPARED AS A RESINOUS VEHICLE IN ANTIFOULING PAINT Nippon Paint Co., Ltd. (JP) 1993-09-15 EP disclosed
US-4918147-A REACTING ACID GROUP CONTAINING RESIN WITH LOW BOILING METAL SALT AND HIGH BOILING ORGANIC ACID; ACRYLICS, POLYESTERS, EPOXY RESINS NIPPON PAINT CO., LTD. (JP) 1990-04-17 US disclosed
EP-0342276-A1 A process for preparing a metal containing resin composition and the use of the composition thus prepared as a resinous vehicle in antifouling paint Nippon Paint Co., Ltd. (JP) 1989-11-23 EP disclosed
US-4268509-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-19 US disclosed